Objectives: To review and provide evidence-based recommendations for the diagnosis and treatment of otosclerosis. Methods: Task force members were educated on knowledge synthesis methods, including ...
Molecular characteristics and outcomes of a real-world cohort of carcinoma of unknown primary determined by tissue-of-origin assays. Farnesyl transferase inhibitor (FTI) darlifarnib (KO-2806) in ...
Who gets access? National discrepancies in clinical trial enrollment among patients with brain metastases. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not ...
Abstract: We created Home Based Care (HBC), an innovative care pathway offering an alternative to standard care for People with Parkinson’s (PwP). Despite its success, scalability is limited by ...
cNational Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) for Ophthalmology, Moorfields Hospital London NHS Foundation Trust, and Institute of Ophthalmology, University ...
Company initiates clinical strategy across multiple therapeutic areas to validate its scalable approach for identifying clinic-ready synergistic combinations of approved drugs CAMBRIDGE, ...
Rare diseases encompass a wide range of over 7,000 distinct conditions that affect a relatively small number of individuals. While each condition may be uncommon on its own, collectively they impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results